Home › Compare › PRVCF vs FCPT

PRVCF vs FCPT: Dividend Comparison 2026

PRVCF yields 14285.71% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRVCF wins by $1868328188208921344.00M in total portfolio value
10 years
PRVCF
PRVCF
● Live price
14285.71%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1868328188208921344.00M
Annual income
$1,842,950,648,126,759,800,000,000.00
Full PRVCF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — PRVCF vs FCPT

📍 PRVCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRVCFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRVCF + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PRVCF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRVCF
Annual income on $10K today (after 15% tax)
$1,214,285.71/yr
After 10yr DRIP, annual income (after tax)
$1,566,508,050,907,746,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, PRVCF beats the other by $1,566,508,050,907,746,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRVCF + FCPT for your $10,000?

PRVCF: 50%FCPT: 50%
100% FCPT50/50100% PRVCF
Portfolio after 10yr
$934164094104460672.00M
Annual income
$921,475,324,063,379,900,000,000.00/yr
Blended yield
98.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

PRVCF
No analyst data
Altman Z
-138.3
Piotroski
1/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRVCF buys
0
FCPT buys
0
No recent congressional trades found for PRVCF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRVCFFCPT
Forward yield14285.71% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1868328188208921344.00M ✓$49.1K
Annual income after 10y$1,842,950,648,126,759,800,000,000.00 ✓$5,775.28
Total dividends collected$1866648039868218112.00M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PRVCF vs FCPT ($10,000, DRIP)

YearPRVCF PortfolioPRVCF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$1,439,271$1,428,571.43$11,401$700.92+$1.43M → PRVCF
2$193,699,090$192,159,069.24$13,064$864.84+$193.69M → PRVCF
3$24,376,441,818$24,169,183,791.94$15,051$1,072.48+$24376.43M → PRVCF
4$2,868,716,750,186$2,842,633,957,441.24$17,442$1,337.22+$2868716.73M → PRVCF
5$315,716,708,842,374$312,647,181,919,674.60$20,340$1,677.08+$315716708.82M → PRVCF
6$32,495,195,455,130,188$32,157,378,576,668,850.00$23,880$2,116.57+$32495195455.11M → PRVCF
7$3,128,044,259,554,657,300$3,093,274,400,417,667,600.00$28,241$2,689.36+$3128044259554.63M → PRVCF
8$281,631,115,249,329,080,000$278,284,107,891,605,600,000.00$33,660$3,442.07+$281631115249329.06M → PRVCF
9$23,717,327,179,590,366,000,000$23,415,981,886,273,583,000,000.00$40,456$4,439.95+$23717327179590368.00M → PRVCF
10$1,868,328,188,208,921,400,000,000$1,842,950,648,126,759,800,000,000.00$49,063$5,775.28+$1868328188208921344.00M → PRVCF

PRVCF vs FCPT: Complete Analysis 2026

PRVCF — Stock

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Full PRVCF Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this PRVCF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRVCF vs SCHDPRVCF vs JEPIPRVCF vs OPRVCF vs KOPRVCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.